1. Home
  2. RXT vs MRVI Comparison

RXT vs MRVI Comparison

Compare RXT & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXT
  • MRVI
  • Stock Information
  • Founded
  • RXT 1998
  • MRVI 2014
  • Country
  • RXT United States
  • MRVI United States
  • Employees
  • RXT N/A
  • MRVI N/A
  • Industry
  • RXT EDP Services
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • RXT Technology
  • MRVI Health Care
  • Exchange
  • RXT Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • RXT 280.1M
  • MRVI 371.8M
  • IPO Year
  • RXT 2020
  • MRVI 2020
  • Fundamental
  • Price
  • RXT $1.26
  • MRVI $2.42
  • Analyst Decision
  • RXT Hold
  • MRVI Hold
  • Analyst Count
  • RXT 5
  • MRVI 10
  • Target Price
  • RXT $1.58
  • MRVI $5.84
  • AVG Volume (30 Days)
  • RXT 764.7K
  • MRVI 1.5M
  • Earning Date
  • RXT 08-07-2025
  • MRVI 08-11-2025
  • Dividend Yield
  • RXT N/A
  • MRVI N/A
  • EPS Growth
  • RXT N/A
  • MRVI N/A
  • EPS
  • RXT N/A
  • MRVI N/A
  • Revenue
  • RXT $2,693,100,000.00
  • MRVI $219,830,000.00
  • Revenue This Year
  • RXT N/A
  • MRVI N/A
  • Revenue Next Year
  • RXT $1.48
  • MRVI $7.23
  • P/E Ratio
  • RXT N/A
  • MRVI N/A
  • Revenue Growth
  • RXT N/A
  • MRVI N/A
  • 52 Week Low
  • RXT $1.00
  • MRVI $1.67
  • 52 Week High
  • RXT $3.41
  • MRVI $9.60
  • Technical
  • Relative Strength Index (RSI)
  • RXT 52.70
  • MRVI 49.60
  • Support Level
  • RXT $1.14
  • MRVI $2.28
  • Resistance Level
  • RXT $1.31
  • MRVI $2.47
  • Average True Range (ATR)
  • RXT 0.08
  • MRVI 0.14
  • MACD
  • RXT 0.01
  • MRVI -0.01
  • Stochastic Oscillator
  • RXT 79.55
  • MRVI 27.45

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: